John Olynyk
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
John Olynyk
Chief Medical Officer / Resonance Health
Most Notable Role
Professor John Olynyk is an internationally recognised leader in liver-related diseases including iron-metabolism disorders, hemochromatosis, liver-injury, hepatocellular carcinoma, and non-alcoholic fatty liver disease.
Prof Olynyk won several awards and grants for research projects. He has contributed to over 250 published articles, 180 conference abstracts, authored 11 book chapters and miscellaneous publications including
on the topics of iron in chronic liver disease, iron overload, and brain changes in iron loading disorders. He has also spoken and presented by invitation at dozens of international and national conferences related to liver diseases.
Prof Olynyk studied Medicine and Surgery at the University of Western Australia before becoming an accredited gastroenterologist in 1991.
Prof Olynyk won several awards and grants for research projects. He has contributed to over 250 published articles, 180 conference abstracts, authored 11 book chapters and miscellaneous publications including
on the topics of iron in chronic liver disease, iron overload, and brain changes in iron loading disorders. He has also spoken and presented by invitation at dozens of international and national conferences related to liver diseases.
Prof Olynyk studied Medicine and Surgery at the University of Western Australia before becoming an accredited gastroenterologist in 1991.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 536th | Proteomics International Laboratories | 8% | 26% |
| 628th | Resonance Health | 3% | -7% |
| 840th | HITIQ | -7% | |
| 1612th | Nuheara | -60% | -44% |
| 1835th | Emyria | -78% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
2020
Dean of Clinical Research, Professor of Translational Medicine, Theme Lead for Health Research
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 123rd |  | Resonance Health | $4.5m |
| 130th | | Emyria | $3.8m |
| 131st | | Nuheara | $3.8m |
| 135th |  | HITIQ | $3.2m |
| 136th | | Proteomics International Laboratories | $3.2m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Consultant Hepatologist, Department of Gastroenterology, Fiona Stanley Hospital | 24 Nov 2021 |
| NEW ROLE: Gastroenterologist & Hepatologist, South Metropolitan Health Service | 24 Nov 2021 |
| NEW ROLE: Dean of Clinical Research, Professor of Translational Medicine, Theme Lead for Health Research, Edith Cowan University | 24 Nov 2021 |
| NEW ROLE: Chief Medical Officer, Resonance Health | 24 Nov 2021 |
